Welcome!

New IOI Tear Sheet Published on Gilead Sciences ($GILD)

September 22, 2016

We just published a new IOI Tear Sheet to our Members and will very shortly be publishing a more detailed IOI ChartBook as well. Here is a sample. Gilead Sciences (GILD) is a spectacular biotechnology investor. Its 2011 purchase of Pharmasset for $11 billion yielded a revolutionary treatment for Hepatitis C Virus (HCV) that has generated …

Let's Chat

Use the form below to ask us any questions.

SIGN IN

Current students can use this form to access our courses dashboard.



Not a student? Start a Free Trial!

Sign Up to View

Please enter your email to access to gain access to "New IOI Tear Sheet Published on Gilead Sciences ($GILD)"

Contact Information

Know someone else who could benefit from IOI industry leading investment research and investor training?